Liudmila P. Sizyakina

Liudmila P. Sizyakina

Auto-generated profile, based on publicly available information

Liudmila P. Sizyakina

Rostov State Medical University

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2009 in Biochimie
Verified
Journal Article
Closed access
SBSvetlana Baranova
Svetlana Baranova
VBValentina Buneva
Valentina Buneva
MKMarina A. Kharitonova
Marina A. Kharitonova
LSLudmila P. Sizyakina
Ludmila P. Sizyakina
CCChristina Calmels
Christina Calmels
GNGeorgy A. Nevinsky
Georgy A. Nevinsky

1 March 2006 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
EOE. S. Odintsova
E. S. Odintsova
MKM. A. Kharitonova
M. A. Kharitonova
ABA. G. Baranovskii
A. G. Baranovskii
LSL. P. Sizyakina
L. P. Sizyakina
VBValentina Buneva
Valentina Buneva
GNGeorgy Nevinsky
Georgy Nevinsky
Proteolytic activity of polyclonal IgG antibodies (Abs) from the blood of AIDS patients was analyzed for the first time. These Abs were shown to display higher activity in hydrolysis of β-casein than...

6 October 2021 in Russian Journal of Allergy
Verified
Journal Article
Closed access
PDF file
OBOlga S. Bodnya
Olga S. Bodnya
DDDarya V. Demina
Darya V. Demina
NKNatalia B. Kuzmenko
Natalia B. Kuzmenko
TLTatiana Latysheva
Tatiana Latysheva
TLTatiana V. Latysheva
Tatiana V. Latysheva
СПСизякина Людмила Петровна
Сизякина Людмила Петровна
Hereditary angioedema is a rare (orphan) disease associated with the development of angioedema of various localization caused by the action of bradykinin. The main symptoms of the disease are peripheral angioedema, abdominal attacks (accompanied by severe pain syndrome), edema of the upper respiratory tract, which may lead to asphyxia and death of the patient. Peripheral edema disrupts social and professional activity, the occurrence of facial edema complicates social adaptation, the unpredictability and potential threat to life of edema in the larynx, as well as the lack of effect from standard (systemic glucocorticoid and antihistamines) therapy regimens lead to a low quality of life of patients, a large number of days of disability, hospitalizations, in some cases, premature death of patients. According to international studies, on-demand therapy does not reduce the burden of the disease, and therefore international guidelines emphasize the importance of timely and individualized selection of long-term prevention for patients with hereditary angioedema. Taking into account the appearance of a new drug for long-term prevention in Russia, an Expert Council was held to assess the burden of the disease in Russian patients, determine the proportion of patients who need long-term prevention, criteria for choosing a medication for prophylaxis and the place of Lanadelumab in it.

13 July 2022 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
LSL. P. Sizyakina
L. P. Sizyakina
IAI. I. Andrreeva
I. I. Andrreeva
MKM. V. Kharitonova
M. V. Kharitonova
NZN. S. Zaitseva
N. S. Zaitseva
DLD. S. Lyubimov
D. S. Lyubimov
ВЗВ. Я. Закурская
В. Я. Закурская
The relevance of the current epidemic situation of a new coronavirus infection is determined by new strains of the virus and the registration of cases of re-infection in COVID-19 survivors earlier. In this regard, the questions about the expediency and nature of vaccination of those who have been ill attract close attention, moreover it has affected the formation of the concept of “hybrid immunity”. The aim of this study was to analyze changes in the parameters of the immune system, reflecting their regulatory and functional potential, in response to the introduction of the peptide vaccine EpiVacCorona to persons who have suffered from the new coronavirus infection. To study the features of the formation of hybrid immunity, a retrospective analysis of the observation of 43 study participants was carried out. The inclusion criteria were data confirming COVID-19 in mild and moderate forms of the course in the period from six months to a year ago, a low level or absence of antibodies to the nucleocapsid protein SARS-CoV-2, a negative PCR result for the presence of the SARS-CoV-2 virus, the absence of comorbid pathology. The subpopulation composition, regulatory and functional potential of the immune system were determined by flow cytofluorimetry using a set of monoclonal antibodies corresponding to the goals. 21 days after the administration of a single dose of EpiVacCorona, antibodies to the vaccine peptide antigens were registered in all study participants at the highest coefficient of positivity values for the SARS-CoV-2-IgG-Vector test system used. In addition, there was a fourfold increase in the number of specific IgG to the N protein. A specific immune response to recombinant SARS-CoV-2 antigens was accompanied by a decrease in the circulation of the number of monocytes expressing TLR4, T helper cells expressing the interaction coreceptor with antigen-presenting cells, unconnected B memory with an increase in the number of B lymphocytes expressing the CD40 T-B coreceptor interaction molecule. The remaining differences in the functioning of the immune system identified in patients with COVID-19 before the vaccination in comparison with the control data have not changed. The differences consist in a decrease in the proportion of monocytes expressing HLA-DR, an increase in the expression of interaction molecules on T and B lymphocytes, an increase in the number of Treg, B1 cells, activated B lymphocytes with a decrease in the proportion of suppressor Breg and B memory. The totality of the presented data demonstrates that the COVID-19 infection that preceded vaccination in mild and moderate clinical course contributes to the formation of immunological memory, which made it possible to form a secondary immune response even to a single injection of peptide antigens of the virus.

27 September 2013 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
LSL. P. Sizyakina
L. P. Sizyakina
IAI. I. Andreeva
I. I. Andreeva
Традиционно считается, что первичные иммунодефицитные состояния (ПИД) — редкие заболевания. Тем не менее частота встречаемости ПИД в Европе существенно выше, чем в России: наша статистика по заболеваниям врожденными иммунодефицитами далека от истинного положения вещей. Опыт создания регистра пациентов ПИД в Ростовской области доказал, что сочетание организационных и образовательных мероприятий способствует своевременной диагностике, рациональной терапии и улучшению качества жизни пациентов с первичными иммунодефицитами.

20 April 2022 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
LSL. P. Sizyakina
L. P. Sizyakina
IAI. I. Andrreeva
I. I. Andrreeva
MKM. V. Kharitonova
M. V. Kharitonova
NZN. S. Zaitseva
N. S. Zaitseva
DLD. S. Lyubimov
D. S. Lyubimov
ВЗВ. Я. Закурская
В. Я. Закурская
The dominance of reliably immunized population is a fundamental factor in prevention of COVID-19 pandemia, with immune prophylaxis taking a dominant position. Due to lack of clear data on the intensity of specific immunity after a new coronavirus infection, consolidation of immunological memory by vaccination becomes the urgent task, in order to exclude the risk of re-involvement of previously ill patients into the epidemic process. Meanwhile, many questions related to vaccination of COVID-19 survivors do not get distinct answers. To study the features of immune response, using a vaccine based on SARS-CoV-2 peptide antigens (EpiVacCorona), we monitored 81 participants. The inclusion criteria were data confirming COVID-19 in the anamnesis (medical documentation), low levels or absence of antibodies to the SARS-CoV-2 nucleocapsid protein, and negative PCR tests for SARS-CoV-2. When assessing the data of post-vaccinal immunity checked 21 days after 1st dose of the vaccine, the patients were divided into 2 groups: those who did not respond, and those who developed the immune response. In order to identify possible reasons for different phenotypic patterns of humoral response to vaccination, a comparative analysis of B lymphocyte indexes was carried out in these groups. Absolute counts, subpopulation composition and activation potential of peripheral blood B lymphocytes were determined by flow cytofluorometry using appropriate labeled monoclonal antibodies purchased from Beсkman Coulter. Comparative analysis of B lymphocyte indexes on the day of first vaccination showed that the persons who did not respond to the vaccine had smaller counts of circulating B cells, i.e., both percentage and absolute cell numbers, than in comparison group, as well as changed ratio of B1-to-B2 subpopulations. After administration of the first vaccine dose (by day +21), in alternative variant of the antibody response to V1, the differences in the parameters of B cells were presented as a smaller percentage and absolute numbers of regulatory B lymphocytes in non-responding participants. Moreover, the contents of minor B cell subpopulations were decreased in the non-responding group than in the comparison group, thus affecting the values of the B1:B2 ratio. In general, the presented data demonstrate that the absence of secondary immune response to antigens of the SARS-CoV-2 peptide vaccine could be is associated with altered differentiation of B1 and B2 subpopulations, B regulatory lymphocytes, B memory cells.